RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sana Biotechnology Stock

Sana Biotechnology Equity 2024

Sana Biotechnology Equity

287.51 M USD

Ticker

SANA

ISIN

US7995661045

In 2024, Sana Biotechnology's equity was 287.51 M USD, a -42.42% increase from the 499.3 M USD equity in the previous year.

Sana Biotechnology Aktienanalyse

What does Sana Biotechnology do?

Sana Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Sana Biotechnology's Equity

Sana Biotechnology's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sana Biotechnology's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sana Biotechnology's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sana Biotechnology's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sana Biotechnology’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sana Biotechnology stock

What is the equity of Sana Biotechnology this year?

Sana Biotechnology has equity of 287.51 M USD this year.

What was the equity of Sana Biotechnology compared to the previous year?

The equity of Sana Biotechnology has increased/decreased by -42.42% decreased compared to the previous year.

What impact does a high equity have on investors of Sana Biotechnology?

A high equity is advantageous for investors of Sana Biotechnology as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Sana Biotechnology?

A low equity can be a risk for investors of Sana Biotechnology, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Sana Biotechnology affect the company?

An increase in equity of Sana Biotechnology can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Sana Biotechnology affect the company?

A reduction in equity of Sana Biotechnology can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Sana Biotechnology?

Some factors that can affect the equity of Sana Biotechnology include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Sana Biotechnology so important for investors?

The equity of Sana Biotechnology is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Sana Biotechnology take to change the equity?

To change equity, Sana Biotechnology can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Sana Biotechnology pay?

Over the past 12 months, Sana Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sana Biotechnology is expected to pay a dividend of 0 USD.

What is the dividend yield of Sana Biotechnology?

The current dividend yield of Sana Biotechnology is .

When does Sana Biotechnology pay dividends?

Sana Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sana Biotechnology?

Sana Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Sana Biotechnology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sana Biotechnology located?

Sana Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sana Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sana Biotechnology from 11/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/25/2024.

When did Sana Biotechnology pay the last dividend?

The last dividend was paid out on 11/25/2024.

What was the dividend of Sana Biotechnology in the year 2023?

In the year 2023, Sana Biotechnology distributed 0 USD as dividends.

In which currency does Sana Biotechnology pay out the dividend?

The dividends of Sana Biotechnology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sana Biotechnology

Our stock analysis for Sana Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sana Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.